What Will it Take to Bring New Pain Therapies to the Market? A New Season of the I am BIO Podcast Explores
Spring 2023 Season Takes a Deep Dive Into
Pain Therapies, Artificial Intelligence, FDA’s Accelerated Approvals, and Misinformation
Today, the Biotechnology Innovation Organization (BIO) premieres its new I am BIO podcast season, which tells powerful stories of biotech breakthroughs, the people they help, and the global problems they solve.
“We want the American public to know they can trust science and biotechnology innovations, which are improving and saving lives,” said BIO’s CEO Rachel King. “By sharing our industry’s unique approaches to helping solve some of the world’s most pressing problems, we’re arming our listeners with first-hand insight into the exciting world of biotechnology.”
The season launches with a topic that impacts50 million people in the United States daily –chronic pain–and explores safe and effective treatments and how government policies could hinder new treatment developments.
Each year the podcast releases 12 episodes – six in the spring and six beginning in September. The first half of the season will culminate with an episode on science and health misinformation.
Additional episodes during the spring season will cover:
- The convergence of artificial intelligence and biotechnology
- Biotech innovation with CRISPR technology
- Threats to FDA’s Accelerated Approval program
In 2022, PR Daily named the I AM BIO podcast a finalist for its Social Media & Digital Awards in the podcast category. Listen now on BIO’s website, Apple Podcasts, Google Podcasts, or Spotify.